Related Experiment Videos
Potassium clorazepate (Tranxene)-induced jaundice
Postgraduate Medical Journal
|December 1, 1979
Summary
This study reports a probable case of jaundice and liver damage linked to potassium clorazepate. The findings suggest caution when prescribing this drug to patients with existing liver issues.
Area of Science:
- Hepatology
- Clinical Pharmacology
Background:
- Potassium clorazepate is a commonly prescribed medication.
- Drug-induced liver injury (DILI) is a significant clinical concern.
- The hepatotoxic potential of potassium clorazepate requires further investigation.